Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

charlie-mayr_1

Actavis confirms retirement of its comms officer

April 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, charles mayr

Ireland-based pharma firm Actavis has announced its chief communications officer Charles Mayr (pictured) is to retire shortly due to health …
Appointment
jeroen_tonnaer

Cristal Therapeutics hires chief business officer from Merck

April 23, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cristal Therapeutics, Jeroen Tonnaer, Merck

Jeroen Tonnaer has been named as the new chief business officer responsible for Cristal Therapeutics’ business development, partnering and licensing …
Appointment
Pfizer image

Two oncology successes for Pfizer

April 22, 2015 Research and Development, Sales and Marketing Cancer, FDA, Inotuzumab ozogamicin, NSCLC, Pfizer, Xalkori, oncology

Pfizer has received two boosts in oncology as Xalkori gets a new breakthrough therapy designation from the FDA, and its …
News
goran_ando

EUSA Pharma appoints chief executive and director

April 22, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley

Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) …
Appointment
Teva image

Teva moves to buy Mylan

April 21, 2015 Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger

Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
News
Pfizer image

Merck KGaA and Pfizer alliance begins lung cancer study

April 21, 2015 Research and Development, Sales and Marketing Merck KGaA, Pfizer, avelumab, keytruda, oncology, opdivo

Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …
News

Novartis MS drug scores positive late-stage trial result

April 21, 2015 Research and Development, Sales and Marketing MS, Novartis, fingolimod, gilenya, multiple sclerosis

People with some of the most common forms of multiple sclerosis (MS) who are treated with Gilenya are less likely …
News
vivian_huang

Four join the ranks of IDEA Pharma

April 21, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anastasia Liapis, Cindy Peché, IDEA Pharma, Louise Ward, Vivian Huang

IDEA Pharma has made four new appointments in Louise Ward as project manager and Cindy Peché as head of group …
Appointment
EU image

What you need to know about the EU Clinical Trial Regulation

April 20, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EU Clinical Trial Regulation, EU-CTR, Virginia Acha

 Where did the EU Clinical Trial Regulation come from? The EU Clinical Trial Regulation (EU-CTR) was approved in April 2014 …
Feature
michael_w

Celgene appoints former Cubist chief executive

April 20, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, cubist, michael bonney

Celgene has elected pharma veteran Michael Bonney to join its board of directors. Bonney served as chief executive and board …
Appointment
GSK image

GSK sees further US job losses following Novartis deal

April 17, 2015 Research and Development, Sales and Marketing GSK, Jobs, Novartis, cuts, merger, pittsburgh, restructuring

Hundreds more jobs are at risk within GlaxoSmithKline as the fallout from the company’s asset-swapping deal with Novartis continues. Staff …
News
Ken Frazier image

Merck chief executive replaces Pfizer boss as PhRMA chairman

April 17, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing George Scangos, Ian Read, Joaquin Duato, Kenneth Frazier, PhRMA

Chairman and chief executive of Merck Kenneth Frazier is to replace Pfizer boss Ian Read as chairman at the Pharmaceutical …
News
alise_reicin

Merck Serono gains head of global clinical development

April 17, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alise Reicin, Merck, Merck Serono

Merck Serono, the biopharma business of Merck, has appointed Dr Alise Reicin as senior vice president and head of its …
Appointment
MedImmune image

AstraZeneca signs immuno-oncology deal with UK firm

April 16, 2015 Research and Development, Sales and Marketing AstraZeneca, IMCgp100, MEDI4736, MedImmune, Oxford, immuno-oncology, immunocore, melanoma, tremelimumab

UK pharma and biotech firms AstraZeneca and Immunocore are teaming up to launch early-stage studies of potential new cancer treatments. …
News
Sun Pharmaceutical Industries, India

Sun Pharma and Technion form oncology research pact

April 16, 2015 Research and Development, Sales and Marketing Cancer, Sun Pharma, institute of technology, oncology, technion

Mumbai-based Sun Pharmaceuticals Industries is teaming up with the Israel Institute of Technology Technion to develop new oncology drugs. This …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026